Analgesic effects of receptin, a chemically modified cobratoxin from Thailand cobra venom

Neuroscience Bulletin

Volumn 22, Issue 5, 2006, Pages 267-273

  Zhang, Hui Ling ^a   Han, Rong ^a   Chen, Zhi Xing ^a   Gu, Zhen Lun ^a   Reid, Paul F ^b   Raymond, Laurence N ^b   Qin, Zheng Hong ^a  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b ReceptoPharm   (United States)

Author keywords

Analgesia; Atropine; Central nervous system; Naloxone; Receptin

Indexed keywords

ATROPINE; COBROTOXIN; NALOXONE; SOLUBLE CD4 ANTIGEN;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CHEMICAL MODIFICATION; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; HOT PLATE TEST; MALE; MOTOR ACTIVITY; MOUSE; NONHUMAN; PAIN; PEPTIDERGIC NERVOUS SYSTEM; RAT; SNAKE; TAIL FLICK TEST; WRITHING TEST;

EID: 33847776139     PISSN: 16737067     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Macht DI. Experimental and clinical study of cobra venom as an analgesic. Proc Natl Acad Sci USA 1936, 22: 61-71.
2. Van Esveld LN. Preparation of cobratoxin for clinical purposes especially in the treatment of cancer pains. Biochemische Zeitschrift 1936, 283: 343-357.
3. Mancin AC, Soares AM, Andriao-Escarso SH, Faca VM, Greene LJ, Zuccolotto S, et al. The analgesic activity of crotamine, a neurotoxin from Crotalus durissus terrificus (South American rattlesnake) venom: a biochemical and pharmacological study. Toxicon 1998, 36:1927-1937.
4. Corin RE, Viskatis LJ, Vidal JC, Etcheverry MA. Cytotoxicity of crotoxin on murine erythroleukemia cells in vitro. Invest New Drugs 1993, 11: 11-15.
5. Rudd CJ, Viskatis LJ, Vidal JC, Etcheverry MA. In vitro comparison of cytotoxic effects of crotoxin against three human tumors and normal human epidermal keratinocyte cell line. Invest New Drugs 1994, 12: 183-184.
6. 2, NSC-624244) in patient with advanced cancer. Clin Cancer Res 2002, 8: 1033-1041.
7. Chen R, Robinson SE. Effect of cholinergic manipulations on the analgesic response to cobrotoxin in mice. Life Sci 1990, 47: 1949-1954.
8. Zhang HL, Han R, Gu ZL, Chen ZX, Chen BW, Reid PF, et al. A short-chain α-neurotoxin from Naja naja atra produces potent cholinergic-dependent analgesia. Neurosci Bull 2006, 22: 103-109.
9. Chen ZX, Zhang HL, Gu ZL, Chen BW, Han R, Reid PF, et al. A long-form α-neurotoxin from cobra venom produces potent opioid-independent analgesia. Acta Pharmacol Sin 2006, 27: 402-408.
10. Miller KD, Miller GG, Sanders M, Fellowes O. Inhibition of virus-induced plaque formation by atoxic derivatives of purified cobra neurotoxin. Biochim Biophys Acta 1977, 496: 192-196.
11. Yourist JE, Haines HG, Miller KD. Inhibition of Herpes Simplex virus replication by cobra α-neurotoxin. J Gen Virol 1983, 64: 1475-1481.
12. Clark WB, Baldone JA, Thomas CI. The use of sanders neurotoxoid I (modified snake venom) in the treatment of recurrent herpes simplex of the cornea: progress report. South Med J 1962, 55: 947-951.
13. Sanders M, Fellowes ON. Use of detoxified snake neurotoxin as a partial treatment for Amyotrophic Lateral Sclerosi. Cancer Cytol 1975, 15: 26-30.
14. Rivera VM, Grabois M, Deaton W, Breitbach W, Hines M. Modified snake venom in amyotrophic lateral sclerosis. Arch Neurol 1979, 37: 201-203.
15. Vargas F, Cortes M. Primera experiencia en el tratamiento de infecciones herpeticas con neuevo antiviral (peptido-E o immunoquina). Rev Chil de Urol 1995, 60: 242-246.
16. Mundy H, Jones S, Lee P. A randomised controlled study of modified cobratoxin in adrenomyeloneuropathy. Neurology 2003, 61: 528-530.
17. nd ed. San Diego: Academic Press, 1986: 45-51.
18. Servent D, Anti-Delbeke S, Gaillard C, Corringer PJ, Changeux JP, Menenz A. Molecular characterization of the specificity of interactions of various neurotoxins on two distinct nicotinic acetylcholine receptors. Eur J Pharmacol 2000, 393: 197-204.
19. Dajas-Bailador F, Costa G, Dajas F, Emmett S. Effects of α-erabutoxin, α-bungarotoxin, α-cobratoxin and fasciculin on the nicotine-evoked release of dopamine in the rat striatum in vivo. Neurochem Intl 1998, 33: 307-312.
20. Zeng HY, Hawrot E. NMR-based binding screen and structural analysis of the complex formed between α-cobratoxin and an 18-Mer cognate peptide derived from the α1 subunit of the nicotinic acetylcholine receptor from Torpedo californica. J Biol Chem 2002, 277: 37439-37445.
21. Tseng LF, Chiu TH, Lee CY. Absorption and distribution of I-Labeled cobra venom and its purified toxins. Tox Appl Pharmacol 1968, 12: 526-535.
22. Khan IM, Taylor P, Yaksh TL. Cardiovascular and behavioral responses to nicotinic agents administered intrathecally. J Pharmacol Exp Ther 1994, 270:150-158.
23. Pedigo NW, Dewey WL, Harris LS. Determination and characterization of the antinociceptive activity of intraventricularly administered acetylcholine in mice. J Pharmacol Exp Ther 1975, 193: 845-852.
24. Harris LS, Dewey WL. Role of cholinergic systems in the central action of narcotic agonists and antagonists. In: Agonist and antagonist actions of narcotic analgesic drugs. Kosterlitz HW, Collier HOJ, Villareal JE, Eds. London: Macmillan Press 1972, 198-206.
25. Giorgi R., Bernardi MM, Cury Y. Analgesic effect evoked by low molecular weight substances extracted from Crotalus durissus terrificus venom. Toxicon 1993, 31: 1257-1365.
26. Mohamed A, Reid PF, Raymond L, Dufan T. Amelioration of acute and relapsing stages of the experimental allergic encephalomyelitis by cobra toxins. Biomed Sci Instrum 2006, 42: 399-404.
27. Zhang HL, Han R, Chen ZX, Chen BW, Gu ZL, Reid PF, et al. Opiate and acetylcholine-independent analgesic actions of crotoxin isolated from crotalus durissus terrificus venom. Toxicon 2006, 48: 175-182.